Nasdaq · Healthcare
OPKO HEALTH, INC. (OPK)
As-reported financials and recent SEC filings for OPKO HEALTH, INC., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$606.9M
Net income
$-225.7M
Net margin
-37.2%
Diluted EPS
$-0.30
ROE
-17.8%
P/E (TTM)
—
Market cap
$1.16B
Debt / equity
0.0×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $606.9M | $713.1M | $863.5M | $1.00B | $1.77B |
| Gross profit | $205.9M | $218.5M | $318.1M | $288.2M | — |
| Operating income | $-117.4M | $-152.1M | $-157.0M | $-226.3M | $18.8M |
| Net income | $-225.7M | $-53.2M | $-188.9M | $-328.4M | $-30.1M |
| Diluted EPS | $-0.30 | $-0.08 | $-0.25 | $-0.46 | $-0.05 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-06-22
View on EDGAR →42026-06-22
View on EDGAR →42026-06-22
View on EDGAR →42026-06-22
View on EDGAR →42026-06-22
View on EDGAR →42026-06-22
View on EDGAR →8-K2026-06-18
View on EDGAR →DEFA14A2026-05-15
View on EDGAR →Go deeper on OPK
Search OPKO HEALTH, INC.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.